Data / Form D filings / BIOVENTRIX, INC.
BIOVENTRIX, INC.: Form D filing
BIOVENTRIX, INC., a biotechnology company in Mansfield, MA, filed a Form D with the SEC in 2026. The latest, on October 8, 2026, reports $1.2 million sold of a $3 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 120 FORBES BLVD. SUITE 125, Mansfield, MA, 02048
- Phone
- (925) 830-1000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1283259
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 8 | New notice | $3,000,000 | $1,200,000 | $1,800,000 | 6 | Sep 29 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Steven Chartier | Executive Officer, Director | |
| Dave Richmond | Executive Officer, Director | |
| Rishi Puri | Director | |
| Mark Ravich | Director | |
| William Abraham | Director |
Other biotechnology companies in Massachusetts that filed recently
- LeanBio Therapeutics, Inc. offering · Oct 22
- Quiver Holdings Inc. $3 million · Oct 21
- Axelyf, Inc. $2.6 million · Oct 13
- Opus KSD, Inc. $680,801 · Oct 1
Every Form D from the week of Oct 5 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BIOVENTRIX, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.